VIEWRAY INC (VRAY)
US92672L1070 - Common Stock
We assign a fundamental rating of 2 out of 10 to VRAY. VRAY was compared to 193 industry peers in the Health Care Equipment & Supplies industry. While VRAY seems to be doing ok healthwise, there are quite some concerns on its profitability. VRAY is quite expensive at the moment. It does show a decent growth rate.
1. Profitability
1.1 Basic Checks
In the past year VRAY has reported negative net income.
VRAY had a negative operating cash flow in the past year.
VRAY had negative earnings in each of the past 5 years.
In the past 5 years VRAY always reported negative operating cash flow.
1.2 Ratios
The profitability ratios for VRAY are negative, so there is not much use analyzing them.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | N/A | ||
| ROE | N/A | ||
| ROIC | N/A |
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
With a Gross Margin value of 8.05%, VRAY is not doing good in the industry: 85.00% of the companies in the same industry are doing better.
VRAY's Gross Margin has declined in the last couple of years.
VRAY does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 8.05% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5Y-11.97%
2. Health
2.1 Basic Checks
VRAY does not have a ROIC to compare to the WACC, probably because it is not profitable.
VRAY has more shares outstanding than it did 1 year ago.
The number of shares outstanding for VRAY has been increased compared to 5 years ago.
VRAY has a worse debt/assets ratio than last year.
2.2 Solvency
Based on the Altman-Z score of -6.16, we must say that VRAY is in the distress zone and has some risk of bankruptcy.
VRAY has a Altman-Z score of -6.16. This is in the lower half of the industry: VRAY underperforms 72.00% of its industry peers.
There is no outstanding debt for VRAY. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | N/A | ||
| Altman-Z | -6.16 |
ROIC/WACCN/A
WACC6.05%
2.3 Liquidity
A Current Ratio of 1.16 indicates that VRAY should not have too much problems paying its short term obligations.
VRAY has a Current ratio of 1.16. This is amonst the worse of the industry: VRAY underperforms 91.00% of its industry peers.
A Quick Ratio of 0.86 indicates that VRAY may have some problems paying its short term obligations.
VRAY has a Quick ratio of 0.86. This is amonst the worse of the industry: VRAY underperforms 90.00% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.16 | ||
| Quick Ratio | 0.86 |
3. Growth
3.1 Past
The Earnings Per Share has been growing slightly by 6.25% over the past year.
Looking at the last year, VRAY shows a very strong growth in Revenue. The Revenue has grown by 44.09%.
VRAY shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 24.59% yearly.
EPS 1Y (TTM)6.25%
EPS 3YN/A
EPS 5YN/A
EPS growth Q2Q-14.29%
Revenue 1Y (TTM)44.09%
Revenue growth 3Y5.2%
Revenue growth 5Y24.59%
Revenue growth Q2Q19.38%
3.2 Future
The Earnings Per Share is expected to grow by 15.77% on average over the next years. This is quite good.
Based on estimates for the next years, VRAY will show a quite strong growth in Revenue. The Revenue will grow by 18.71% on average per year.
EPS Next Y12.95%
EPS Next 2Y18.04%
EPS Next 3Y15.77%
EPS Next 5YN/A
Revenue Next Year-9.41%
Revenue Next 2Y11.46%
Revenue Next 3Y18.71%
Revenue Next 5YN/A
3.3 Evolution
Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
4. Valuation
4.1 Price/Earnings Ratio
VRAY reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for VRAY. No positive earnings are expected for the next year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
A more expensive valuation may be justified as VRAY's earnings are expected to grow with 15.77% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y18.04%
EPS Next 3Y15.77%
5. Dividend
5.1 Amount
VRAY does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
VIEWRAY INC
NASDAQ:VRAY (7/25/2023, 7:15:48 PM)
After market: 0.0251 +0 (+0.4%)0.025
-0.02 (-39.9%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap4.58M
Analysts
Price Target
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | |||
| P/FCF | |||
| P/OCF | |||
| P/B | |||
| P/tB | |||
| EV/EBITDA |
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | N/A | ||
| ROE | N/A | ||
| ROCE | |||
| ROIC | |||
| ROICexc | |||
| ROICexgc | |||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 8.05% | ||
| FCFM |
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.45
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | |||
| Debt/EBITDA | |||
| Cap/Depr | |||
| Cap/Sales | |||
| Interest Coverage | |||
| Cash Conversion | |||
| Profit Quality | |||
| Current Ratio | 1.16 | ||
| Quick Ratio | 0.86 | ||
| Altman-Z |
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)6.25%
EPS 3YN/A
EPS 5Y
EPS growth Q2Q
EPS Next Y12.95%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)44.09%
Revenue growth 3Y5.2%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y